Skip to main content

Eukles Asset Management

SEC CIK
0001632553
Latest filing
Aug 5, 2026

RMD holding history

Resmed Inc in every 13F filed by Eukles Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RMD overviewAll 13F holders of RMDFull Q2 2026 holdings

Shares (Q2 2026)
18,756
Value
$3.66M
% of portfolio
1.5%
Quarters held
22
Since Q1 2021
Holdings of RMD by Eukles Asset Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,756$3.66M1.5%−657−3.4%ReducedHolders
Q1 202619,413$4.36M1.9%−3,323−14.6%ReducedHolders
Q4 202522,736$5.48M2.1%−129−0.6%ReducedHolders
Q3 202522,865$6.26M2.4%−73−0.3%ReducedHolders
Q2 202522,938$5.92M2.4%+43+0.2%AddedHolders
Q1 202522,895$5.13M2.2%+562+2.5%AddedHolders
Q4 202422,333$5.11M2.2%−933−4.0%ReducedHolders
Q3 202423,266$5.68M2.3%−89−0.4%ReducedHolders
Q2 202423,355$4.47M1.9%+87+0.4%AddedHolders
Q1 202423,268$4.61M2.0%+895+4.0%AddedHolders
Q4 202322,373$3.85M1.8%+100.0%AddedHolders
Q3 202322,363$3.31M1.7%+270+1.2%AddedHolders
Q2 202322,093$4.83M2.5%+172+0.8%AddedHolders
Q1 202321,921$4.80M2.6%−84−0.4%ReducedHolders
Q4 202222,005$4.58M2.7%+429+2.0%AddedHolders
Q3 202221,576$4.71M3.1%−17−0.1%ReducedHolders
Q2 202221,593$4.53M2.9%+143+0.7%AddedHolders
Q1 202221,450$5.20M2.8%−569−2.6%ReducedHolders
Q4 202122,019$5.74M2.8%+268+1.2%AddedHolders
Q3 202121,751$5.73M3.1%+1,176+5.7%AddedHolders
Q2 202120,575$5.07M2.8%+1,354+7.0%AddedHolders
Q1 202119,221$3.73M2.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.